Relationship Between Thyroid Dysfunction and Diabetes

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorAssiut University

About this trial

Evaluate the expression of glycemic parameters, lipid profile, and thyroid hormones in patients with type 2 diabetes mellitus in upper egypt.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients diagnosed with type 2 diabetes mellitus in upper egypt.

Age above 18 years.

Patients who gave informed consent to participate.

Disqualifiers

Patients with type 1 diabetes mellitus.

Age below 18 years.

Patients with known autoimmune thyroid diseases, pregnancy, or acute illness at the time of assessment.

Trial population

Adult patients aged 18 years and above diagnosed with type 2 diabetes mellitus attending the Diabetes and Endocrinology Outpatient Clinic at Assiut University Hospitals, Upper Egypt.

Trial design

Design model

Other

Time perspective

Cross-sectional

Treatments tested in this trial

  • Observational cross-sectional study with no intervention.

    Other intervention

    This study does not involve any intervention. It is a cross-sectional observational study. The term "intervention" here refers to laboratory investigations and clinical assessments conducted as part of data collection only.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Prevalence of thyroid dysfunction among type 2 diabetic patients

The outcome will measure the proportion (%) of type 2 diabetic patients diagnosed with thyroid dysfunction. This includes classification into hypothyroidism, hyperthyroidism, subclinical hypothyroidism, and subclinical hyperthyroidism based on standard laboratory cutoffs of TSH, free T3, and free T4.

Time frame
Baseline
2

Association between thyroid dysfunction and metabolic syndrome in type 2 diabetic patients

The outcome will assess the statistical correlation (e.g., chi-square test or logistic regression) between the presence of thyroid dysfunction and the diagnosis of metabolic syndrome, according to IDF criteria. Results will be reported as odds ratios or p-values as appropriate.

Time frame
Baseline

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: